On Friday, Cabaletta Bio Inc (NASDAQ: CABA) was 3.64% up from the session before settling in for the closing price of $1.65. A 52-week range for CABA has been $0.99 – $6.26.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -20.35% over the past five years. When this article was written, the company’s average yearly earnings per share was at -1.19%. With a float of $68.16 million, this company’s outstanding shares have now reached $91.45 million.
Let’s look at the performance matrix of the company that is accounted for 161 employees. In terms of profitability, gross margin is -34.07%, operating margin of -9149.76%, and the pretax margin is -8808.67%.
Cabaletta Bio Inc (CABA) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cabaletta Bio Inc stocks. The insider ownership of Cabaletta Bio Inc is 11.33%, while institutional ownership is 68.19%.
Cabaletta Bio Inc (CABA) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.62 earnings per share (EPS) during the time that was less than consensus figure (set at -0.61) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.27% during the next five years compared to -20.35% drop over the previous five years of trading.
Cabaletta Bio Inc (NASDAQ: CABA) Trading Performance Indicators
You can see what Cabaletta Bio Inc (CABA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.71, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -1.77 in one year’s time.
Technical Analysis of Cabaletta Bio Inc (CABA)
Cabaletta Bio Inc (NASDAQ: CABA) saw its 5-day average volume 2.37 million, a positive change from its year-to-date volume of 1.57 million. As of the previous 9 days, the stock’s Stochastic %D was 87.76%.
During the past 100 days, Cabaletta Bio Inc’s (CABA) raw stochastic average was set at 45.00%, which indicates a significant decrease from 91.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1253 in the past 14 days, which was lower than the 0.1444 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6924, while its 200-day Moving Average is $2.0970. Nevertheless, the first resistance level for the watch stands at $1.7400 in the near term. At $1.7700, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.8250. If the price goes on to break the first support level at $1.6550, it is likely to go to the next support level at $1.6000. Assuming the price breaks the second support level, the third support level stands at $1.5700.
Cabaletta Bio Inc (NASDAQ: CABA) Key Stats
There are 91,465K outstanding shares of the company, which has a market capitalization of 156.41 million. As of now, sales total 0 K while income totals -115,860 K. Its latest quarter income was 0 K while its last quarter net income were -45,130 K.
